![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 12683 |
FusionGeneSummary for FAM193A_FGFR3 |
![]() |
Fusion gene information | Fusion gene name: FAM193A_FGFR3 | Fusion gene ID: 12683 | Hgene | Tgene | Gene symbol | FAM193A | FGFR3 | Gene ID | 8603 | 2261 |
Gene name | family with sequence similarity 193 member A | fibroblast growth factor receptor 3 | |
Synonyms | C4orf8|RES4-22 | ACH|CD333|CEK2|HSFGFR3EX|JTK4 | |
Cytomap | 4p16.3 | 4p16.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein FAM193A | fibroblast growth factor receptor 3FGFR-3fibroblast growth factor receptor 3 variant 4hydroxyaryl-protein kinasetyrosine kinase JTK4 | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P78312 | P22607 | |
Ensembl transtripts involved in fusion gene | ENST00000545951, ENST00000382839, ENST00000324666, ENST00000502458, ENST00000505311, | ENST00000481110, ENST00000440486, ENST00000412135, ENST00000340107, ENST00000260795, ENST00000352904, ENST00000474521, | |
Fusion gene scores | * DoF score | 10 X 8 X 8=640 | 3 X 6 X 6=108 |
# samples | 11 | 6 | |
** MAII score | log2(11/640*10)=-2.5405683813627 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FAM193A [Title/Abstract] AND FGFR3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FGFR3 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044 |
Tgene | FGFR3 | GO:0018108 | peptidyl-tyrosine phosphorylation | 11294897 |
Tgene | FGFR3 | GO:0046777 | protein autophosphorylation | 11294897 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SKCM | TCGA-D9-A1X3-06A | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000545951 | ENST00000481110 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000545951 | ENST00000440486 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000545951 | ENST00000412135 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000545951 | ENST00000340107 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000545951 | ENST00000260795 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000545951 | ENST00000352904 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-intron | ENST00000545951 | ENST00000474521 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000481110 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000440486 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000412135 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000340107 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000260795 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000382839 | ENST00000352904 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-intron | ENST00000382839 | ENST00000474521 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000481110 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000440486 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000412135 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000340107 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000260795 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000324666 | ENST00000352904 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-intron | ENST00000324666 | ENST00000474521 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000481110 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000440486 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000412135 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000340107 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000260795 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000502458 | ENST00000352904 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-intron | ENST00000502458 | ENST00000474521 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000481110 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000440486 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000412135 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000340107 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000260795 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-3CDS | ENST00000505311 | ENST00000352904 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
intron-intron | ENST00000505311 | ENST00000474521 | FAM193A | chr4 | 2538897 | + | FGFR3 | chr4 | 1803347 | + |
Top |
FusionProtFeatures for FAM193A_FGFR3 |
![]() |
Hgene | Tgene |
FAM193A | FGFR3 |
Tyrosine-protein kinase that acts as cell-surfacereceptor for fibroblast growth factors and plays an essential rolein the regulation of cell proliferation, differentiation andapoptosis. Plays an essential role in the regulation ofchondrocyte differentiation, proliferation and apoptosis, and isrequired for normal skeleton development. Regulates bothosteogenesis and postnatal bone mineralization by osteoblasts.Promotes apoptosis in chondrocytes, but can also promote cancercell proliferation. Required for normal development of the innerear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads tothe activation of several signaling cascades. Activation of PLCG1leads to the production of the cellular signaling moleculesdiacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylationof FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, andmediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAPkinase signaling pathway, as well as of the AKT1 signalingpathway. Plays a role in the regulation of vitamin D metabolism.Mutations that lead to constitutive kinase activation or impairnormal FGFR3 maturation, internalization and degradation lead toaberrant signaling. Over-expressed or constitutively activatedFGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A andSTAT5B. Secreted isoform 3 retains its capacity to bind FGF1 andFGF2 and hence may interfere with FGF signaling.{ECO:0000269|PubMed:10611230, ECO:0000269|PubMed:11294897,ECO:0000269|PubMed:11703096, ECO:0000269|PubMed:14534538,ECO:0000269|PubMed:16410555, ECO:0000269|PubMed:16597617,ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17311277,ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17561467,ECO:0000269|PubMed:19088846, ECO:0000269|PubMed:19286672,ECO:0000269|PubMed:8663044}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FAM193A_FGFR3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FAM193A_FGFR3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
FAM193A | ANKRD28, MDM4 | FGFR3 | C6orf47, SMG7, BORA, CCDC17, HBZ, HNRNPL, NDUFS6, RNF130, ATF3, ARAP1, CHGB, CTSK, RADIL, GTF3C1, KRT8, POLA2, KIAA1377, RPL8, SLC25A6, SH2B1, FGF9, FGF1, GRB2, FGF8, HSP90AA1, HSP90AB1, HSPA1B, HSPA8, CDC37, HSPA4, SOCS1, SOCS3, FGFR3, SNX11, TMEM231, ILKAP, SRPK2, PVRL1, BRD4, VHL, FNTA, CDK6, FGFR2, TMEM30B, ARRDC3, SDC2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FAM193A_FGFR3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FGFR3 | P22607 | DB00039 | Palifermin | Fibroblast growth factor receptor 3 | biotech | approved |
Tgene | FGFR3 | P22607 | DB06589 | Pazopanib | Fibroblast growth factor receptor 3 | small molecule | approved |
Tgene | FGFR3 | P22607 | DB09079 | Nintedanib | Fibroblast growth factor receptor 3 | small molecule | approved |
Tgene | FGFR3 | P22607 | DB08901 | Ponatinib | Fibroblast growth factor receptor 3 | small molecule | approved|investigational |
Tgene | FGFR3 | P22607 | DB09078 | Lenvatinib | Fibroblast growth factor receptor 3 | small molecule | approved|investigational |
Top |
RelatedDiseases for FAM193A_FGFR3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | FGFR3 | C0022603 | Seborrheic keratosis | 21 | UNIPROT |
Tgene | FGFR3 | C0001080 | Achondroplasia | 8 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0410529 | Hypochondroplasia (disorder) | 8 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0334082 | NEVUS, EPIDERMAL (disorder) | 7 | CTD_human;UNIPROT |
Tgene | FGFR3 | C0005695 | Bladder Neoplasm | 4 | CTD_human |
Tgene | FGFR3 | C1864436 | Muenke Syndrome | 4 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0005684 | Malignant neoplasm of urinary bladder | 3 | UNIPROT |
Tgene | FGFR3 | C2677099 | CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder) | 3 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Tgene | FGFR3 | C0008924 | Cleft Lip | 1 | CTD_human |
Tgene | FGFR3 | C0008925 | Cleft Palate | 1 | CTD_human |
Tgene | FGFR3 | C0026764 | Multiple Myeloma | 1 | CTD_human |
Tgene | FGFR3 | C0036631 | Seminoma | 1 | CTD_human |
Tgene | FGFR3 | C0039743 | Thanatophoric Dysplasia | 1 | CTD_human |
Tgene | FGFR3 | C0265269 | Lacrimoauriculodentodigital syndrome | 1 | CTD_human;ORPHANET;UNIPROT |
Tgene | FGFR3 | C1864852 | CATSHL syndrome | 1 | CTD_human;ORPHANET;UNIPROT |